NCT01265433 2024-10-09
Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
Sellas Life Sciences Group
Phase 2 Completed
Clinical Trials
1 trialsHas results × Mesothelioma, Malignant × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all